Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies
| Autor: | Hyung-Kun Yoon, Ho Kyoung Yoon, Seung Gul Kang, Jun Yeob Lee, Se-Won Lim, Kyoung Uk Lee, Dong Jae Oh, Bun Hee Lee, Jong Chul Yang, Kang Seob Oh, Ho Suk Suh, Seung Min Bae, Young-Do Kwon, Juwon Ha, Hyun Chung Kim, Jihyun Moon, Jae Hon Lee |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
medicine.medical_specialty
Venlafaxine Guideline 03 medical and health sciences 0302 clinical medicine Pharmacotherapy mental disorders medicine Escitalopram 030212 general & internal medicine Psychiatry Social anxiety disorder Biological Psychiatry Sertraline business.industry Social anxiety Initial treatment medicine.disease Paroxetine 030227 psychiatry Psychiatry and Mental health Psychotropic drug Original Article business Anxiety disorder medicine.drug |
| Zdroj: | Psychiatry Investigation |
| ISSN: | 1976-3026 1738-3684 |
| Popis: | Objective The aim of the present study was to provide clinical consensus and evidence regarding initial treatment strategies for the pharmacological treatment of social anxiety disorder (SAD) in Korea. Methods We prepared a questionnaire to derive a consensus from clinicians regarding their preference for the pharmacological treatment of SAD in Korea. Data regarding medication regimens and psychotropic drugs used during initial treatment, the doses used, and the pharmacological treatment duration were obtained. Responses were obtained from 66 SAD experts, and their opinions were classified into three categories (first-line, second-line, third-line) using a chi-square analysis. Results Clinicians agreed upon first-line regimens for SAD involving monotherapy with selective serotonin reuptake inhibitors (SSRIs) or the serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine, or combined therapy using antidepressants with betablockers or benzodiazepines on a standing or as-needed basis. First-line psychotropic drug choices for initial treatment included the following: escitalopram, paroxetine, sertraline, venlafaxine, and propranolol. The medication dosage used by domestic clinicians was found to be comparable with foreign guidelines. Domestic clinicians tended to make treatment decisions in a shorter amount of time and preferred a similar duration of maintenance treatment for SAD when compared with foreign clinicians. Conclusion This study may provide significant information for developing SAD pharmacotherapy guidelines in Korea, especially in the early stage of treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|